Incidence and prevalence of antiphospholipid syndrome (APS) in the USA (2016–2019): a retrospective database study
Meheni Khellaf, Paul Meisner, Maria Sarno, Piotr Zaremba, Adam Jedrzejczyk, Anna Scowcroft · 2024
Read Incidence and prevalence of antiphospholipid syndrome (APS) in the USA (2016–2019): a retrospective database study by Meheni Khellaf, Paul Meisner, Maria Sarno, Piotr Zaremba, Adam Jedrzejczyk, Anna Scowcroft (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11647356.txt.
Description
Meheni Khellaf and five colleagues counted how often antiphospholipid syndrome occurs in the United States, using insurance claims. This autoimmune clotting disorder had few and inconsistent estimates before. The team mined commercial and Medicare supplemental claims data from twenty sixteen to twenty nineteen. A case needed two positive antibody tests at least twelve weeks apart, plus a diagnosis claim. They worked out yearly incidence and prevalence, overall and by subtype.
In total, 1,708 cases met the bar over the four years. Eighty-three percent were women. The standardized yearly incidence rose slightly across the period. Counting from claims misses people with no insurance and people never diagnosed, so these figures are floors. Even so, this twenty twenty-four study gives American clinicians and researchers a firmer sense of how many patients this syndrome affects.
Catalog record
| CREATOR | Meheni Khellaf, Paul Meisner, Maria Sarno, Piotr Zaremba, Adam Jedrzejczyk, Anna Scowcroft |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |